<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39469068</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Potential association between COVID-19 and neurological disorders: analysis of common genes and therapeutics.</ArticleTitle><Pagination><StartPage>1417183</StartPage><MedlinePgn>1417183</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1417183</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2024.1417183</ELocationID><Abstract><AbstractText>As the COVID-19 pandemic persists, the increasing evidences suggest that the patients with COVID-19 may face the risks of the neurological complications and sequelae. To address this issue, we conducted a comprehensive study aimed at exploring the relationship between COVID-19 and various neurological disorders, with a particular focus on the shared dysregulated genes and the potential therapeutic targets. We selected six neurological disorders for investigation, including Alzheimer's disease, epilepsy, stroke, Parkinson's disease, and the sleep disorders. Through the bioinformatics analysis of the association between these disorders and COVID-19, we aimed to uncover the common molecular mechanisms and the potential treatment pathways. In this study, we utilized the publicly available RNA-Seq and microarray datasets, and employed tools such as Limma and DESeq2 for the differential gene analysis. Through the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, we explored the common biological features and pathways. Additionally, we focused on analyzing the regulatory roles of miRNA and transcription factors on the shared differentially expressed genes, and predicted the potential drugs interacting with these genes. These analyses contribute to a better understanding of the relationship between COVID-19 and the neurological disorders, and provide a theoretical basis for the future treatment strategies. Through this research, we aim to offer the deeper insights to the scientific community and present the new perspectives for the clinical practice in addressing the challenges of the neurological complications and sequelae faced by the COVID-19 patients.</AbstractText><CopyrightInformation>Copyright © 2024 Chen, Jiang, Li, Li, Wang and Xu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Wenzhi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, The Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, National Regional Center for Neurological Diseases, Xiangya Hospital of Central South University Jiangxi Hospital, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jiang</LastName><ForeName>Shishi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, The Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, National Regional Center for Neurological Diseases, Xiangya Hospital of Central South University Jiangxi Hospital, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, The Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, National Regional Center for Neurological Diseases, Xiangya Hospital of Central South University Jiangxi Hospital, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, The Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, National Regional Center for Neurological Diseases, Xiangya Hospital of Central South University Jiangxi Hospital, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Renshi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, The Clinical College of Nanchang Medical College, The First Affiliated Hospital of Nanchang Medical College, National Regional Center for Neurological Diseases, Xiangya Hospital of Central South University Jiangxi Hospital, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bioinformatics analysis</Keyword><Keyword MajorTopicYN="N">common dysregulated genes</Keyword><Keyword MajorTopicYN="N">molecular mechanisms</Keyword><Keyword MajorTopicYN="N">neurological disorders</Keyword><Keyword MajorTopicYN="N">therapeutic pathways</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>4</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39469068</ArticleId><ArticleId IdType="pmc">PMC11513677</ArticleId><ArticleId IdType="doi">10.3389/fneur.2024.1417183</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . (2022). Weekly epidemiological update on COVID-19—17 August 2022. Available at:
https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---17-august-2022 (Accessed August 17, 2022).</Citation></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271–280.e8. doi: 10.1016/j.cell.2020.02.052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty PC. What have we learnt so far from COVID-19? Nat Rev Immunol. (2021) 21:67–8. doi: 10.1038/s41577-021-00498-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00498-y</ArticleId><ArticleId IdType="pmc">PMC7805424</ArticleId><ArticleId IdType="pubmed">33442033</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. (2022) 604:697–707. doi: 10.1038/s41586-022-04569-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kacem I, Gharbi A, Harizi C, Souissi E, Safer M, Nasri A, et al. . Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19. Neurol Sci. (2021) 42:39–46. doi: 10.1007/s10072-020-04866-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04866-9</ArticleId><ArticleId IdType="pmc">PMC7670015</ArticleId><ArticleId IdType="pubmed">33201360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougakov D, Podell K, Goldberg E. Multiple neuroinvasive pathways in COVID-19. Mol Neurobiol. (2021) 58:564–75. doi: 10.1007/s12035-020-02152-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02152-5</ArticleId><ArticleId IdType="pmc">PMC7523266</ArticleId><ArticleId IdType="pubmed">32990925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladopoulos T, Zand R, Shahjouei S, Chang JJ, Motte J, Charles James J, et al. . COVID-19: neuroimaging features of a pandemic. J Neuroimaging. (2021) 31:228–43. doi: 10.1111/jon.12819, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12819</ArticleId><ArticleId IdType="pmc">PMC8014046</ArticleId><ArticleId IdType="pubmed">33421032</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, et al. . A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology. (2021) 96:e575–86. doi: 10.1212/WNL.0000000000010979, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010979</ArticleId><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M-H, Perl DP, Nair G, Li W, Maric D, Murray H, et al. . Microvascular injury in the brains of patients with COVID-19. N Engl J Med. (2021) 384:481–3. doi: 10.1056/NEJMc2033369, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Käufer C, Schreiber CS, Hartke A-S, Denden I, Stanelle-Bertram S, Beck S, et al. . Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. (2022) 79:103999. doi: 10.1016/j.ebiom.2022.103999, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103999</ArticleId><ArticleId IdType="pmc">PMC9013202</ArticleId><ArticleId IdType="pubmed">35439679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. (2022) 132:e161167. doi: 10.1172/JCI161167, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. (2022) 28:911–23. doi: 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. (2022) 43:268–70. doi: 10.1016/j.it.2022.02.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Simon NM. Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19. JAMA Psychiatry. (2022) 79:811–7. doi: 10.1001/jamapsychiatry.2022.1616, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1616</ArticleId><ArticleId IdType="pubmed">35767287</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, Stiles LE, Shaik R, Schneider L, Muppidi S, Tsui CT, et al. . Characterization of autonomic symptom burden in long COVID: a global survey of 2,314 adults. Front Neurol. (2022) 13:1012668. doi: 10.3389/fneur.2022.1012668</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. . Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. (2021) 4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative . Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. (2022) 400:452–61. doi: 10.1016/S0140-6736(22)01214-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. . NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. (2013) 41:D991–5. doi: 10.1093/nar/gks1193, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1193</ArticleId><ArticleId IdType="pmc">PMC3531084</ArticleId><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkans U, Füllgrabe A, Ali A, Athar A, Behrangi E, Diaz N, et al. . From ArrayExpress to BioStudies. Nucleic Acids Res. (2021) 49:D1502–6. doi: 10.1093/nar/gkaa1062, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1062</ArticleId><ArticleId IdType="pmc">PMC7778911</ArticleId><ArticleId IdType="pubmed">33211879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. (2015) 43:e47. doi: 10.1093/nar/gkv007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. (2014) 15:550. doi: 10.1186/s13059-014-0550-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H. Ggplot2: elegant graphics for data analysis. New York: Springer; (2009).</Citation></Reference><Reference><Citation>Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. (2012) 16:284–7. doi: 10.1089/omi.2011.0118</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. . STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. (2019) 47:D607–13. doi: 10.1093/nar/gky1131, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Csardi G, Nepusz T. The igraph software package for complex network research. InterJ Complex Syst. (2005) 1695:1–9.</Citation></Reference><Reference><Citation>Pedersen TL. (2022). ggraph: an implementation of grammar of graphics for graphs and networks. Available at:
https://cran.r-project.org/web/packages/ggraph/index.html (Accessed March 07, 2024).</Citation></Reference><Reference><Citation>Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C, et al. . miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. (2020) 48:D148–54. doi: 10.1093/nar/gkz896, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz896</ArticleId><ArticleId IdType="pmc">PMC7145596</ArticleId><ArticleId IdType="pubmed">31647101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, et al. . JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. (2020) 48:D87–92. doi: 10.1093/nar/gkz1001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz1001</ArticleId><ArticleId IdType="pmc">PMC7145627</ArticleId><ArticleId IdType="pubmed">31701148</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. (2019) 47:W234–41. doi: 10.1093/nar/gkz240, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz240</ArticleId><ArticleId IdType="pmc">PMC6602507</ArticleId><ArticleId IdType="pubmed">30931480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. . DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. (2018) 46:D1074–82. doi: 10.1093/nar/gkx1037</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1037</ArticleId><ArticleId IdType="pmc">PMC5753335</ArticleId><ArticleId IdType="pubmed">29126136</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-Y, Hsieh TYJ, Hung Y-M, Oh JW, Chen S-K, Wang S-I, et al. . Prior COVID-19 vaccination and reduced risk of cerebrovascular diseases among COVID-19 survivors. J Med Virol. (2024) 96:e29648. doi: 10.1002/jmv.29648, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29648</ArticleId><ArticleId IdType="pubmed">38727032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferini-Strambi L, Salsone M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol. (2021) 268:409–19. doi: 10.1007/s00415-020-10070-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10070-8</ArticleId><ArticleId IdType="pmc">PMC7372546</ArticleId><ArticleId IdType="pubmed">32696341</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeantin L, Januel E, Labauge P, Maillart E, de Seze J, Zéphir H, et al. . COVID-19 outcomes in patients with multiple sclerosis: understanding changes from 2020 to 2022. Mult Scler. (2024) 30:381–95. doi: 10.1177/13524585231218149, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13524585231218149</ArticleId><ArticleId IdType="pubmed">38247113</ArticleId></ArticleIdList></Reference><Reference><Citation>Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, et al. . Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. (2020) 77:1079–88. doi: 10.1001/jamaneurol.2020.2581, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2581</ArticleId><ArticleId IdType="pmc">PMC7320356</ArticleId><ArticleId IdType="pubmed">32589189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683–90. doi: 10.1001/jamaneurol.2020.1127, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. (2014) 8:S11. doi: 10.1186/1752-0509-8-S4-S11, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. (2003) 13:2498–504. doi: 10.1101/gr.1239303, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Osanai T, Homma Y, Hanada K, Okumura K, Tomita H. IQGAP1 activates PLC-δ1 by direct binding and moving along microtubule with DLC-1 to cell surface. FASEB Bioadv. (2019) 1:465–80. doi: 10.1096/fba.2019-00020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fba.2019-00020</ArticleId><ArticleId IdType="pmc">PMC6996382</ArticleId><ArticleId IdType="pubmed">32123844</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L, Dikalov SI, Chen YE, Tojo T, et al. . IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species—dependent endothelial migration and proliferation. Circ Res. (2004) 95:276–83. doi: 10.1161/01.RES.0000136522.58649.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000136522.58649.60</ArticleId><ArticleId IdType="pubmed">15217908</ArticleId></ArticleIdList></Reference><Reference><Citation>Derakhshani A, Hemmat N, Asadzadeh Z, Ghaseminia M, Shadbad MA, Jadideslam G, et al. . Arginase 1 (Arg1) as an up-regulated gene in COVID-19 patients: a promising marker in COVID-19 immunopathy. J Clin Med. (2021) 10:1051. doi: 10.3390/jcm10051051, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10051051</ArticleId><ArticleId IdType="pmc">PMC7961773</ArticleId><ArticleId IdType="pubmed">33806290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai W, Dai X, Chen J, Zhao J, Xu M, Zhang L, et al. . STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice. JCI Insight. (2019) 4:131355. doi: 10.1172/jci.insight.131355, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.131355</ArticleId><ArticleId IdType="pmc">PMC6824303</ArticleId><ArticleId IdType="pubmed">31619589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Lu Z, Man J, Cui K, Fu X, Yu L, et al. . Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes. Int Immunopharmacol. (2019) 75:105760. doi: 10.1016/j.intimp.2019.105760, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.105760</ArticleId><ArticleId IdType="pubmed">31323530</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Zhang Z, You F. Inhibiting ACSL1-related ferroptosis restrains murine coronavirus infection. Viruses. (2021) 13:2383. doi: 10.3390/v13122383, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122383</ArticleId><ArticleId IdType="pmc">PMC8708337</ArticleId><ArticleId IdType="pubmed">34960652</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran M, Rosen N, Twik M, BarShir R, Stein TI, Dahary D, et al. . The GeneCards suite In: Abugessaisa I, Kasukawa T, editors. Practical guide to life science databases. Singapore: Springer; (2021). 27–56.</Citation></Reference><Reference><Citation>Alam J, Scheper W. Targeting neuronal MAPK14/p38α activity to modulate autophagy in the Alzheimer disease brain. Autophagy. (2016) 12:2516–20. doi: 10.1080/15548627.2016.1238555, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1238555</ArticleId><ArticleId IdType="pmc">PMC5173254</ArticleId><ArticleId IdType="pubmed">27715387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota Y, Yamashita S, Kurihara Y, Jin X, Aihara M, Saigusa T, et al. . Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy. (2015) 11:332–43. doi: 10.1080/15548627.2015.1023047, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1023047</ArticleId><ArticleId IdType="pmc">PMC4502654</ArticleId><ArticleId IdType="pubmed">25831013</ArticleId></ArticleIdList></Reference><Reference><Citation>Höcker R, Walker A, Schmitz I. Inhibition of autophagy through MAPK14-mediated phosphorylation of ATG5. Autophagy. (2013) 9:426–8. doi: 10.4161/auto.22924, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.22924</ArticleId><ArticleId IdType="pmc">PMC3590267</ArticleId><ArticleId IdType="pubmed">23235332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Chen H, Ma J, He Q, Huang Q, Liu Q, et al. . c-Abl–p38α signaling plays an important role in MPTP-induced neuronal death. Cell Death Differ. (2016) 23:542–52. doi: 10.1038/cdd.2015.135</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.135</ArticleId><ArticleId IdType="pmc">PMC5072446</ArticleId><ArticleId IdType="pubmed">26517532</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Sun F, Wang L, Gao M, Xie Y, Sun Y, et al. . Virus-induced p38 MAPK activation facilitates viral infection. Theranostics. (2020) 10:12223–40. doi: 10.7150/thno.50992, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.50992</ArticleId><ArticleId IdType="pmc">PMC7667676</ArticleId><ArticleId IdType="pubmed">33204339</ArticleId></ArticleIdList></Reference><Reference><Citation>COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium . A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell. (2022) 185:916–938.e58. doi: 10.1016/j.cell.2022.01.012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.012</ArticleId><ArticleId IdType="pmc">PMC8776501</ArticleId><ArticleId IdType="pubmed">35216673</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, She H, Zhang T, Xu H, Cheng L, Yepes M, et al. . p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1. J Cell Biol. (2018) 217:315–28. doi: 10.1083/jcb.201701049, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201701049</ArticleId><ArticleId IdType="pmc">PMC5748971</ArticleId><ArticleId IdType="pubmed">29196462</ArticleId></ArticleIdList></Reference><Reference><Citation>She H, He Y, Zhao Y, Mao Z. Release the autophage brake on inflammation: the MAPK14/p38α-ULK1 pedal. Autophagy. (2018) 14:1097–8. doi: 10.1080/15548627.2018.1446626, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1446626</ArticleId><ArticleId IdType="pmc">PMC6103409</ArticleId><ArticleId IdType="pubmed">29749797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Hockerman S, Jacobsen EJ, Alippe Y, Selness SR, Hope HR, et al. . Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. J Exp Med. (2018) 215:1315–25. doi: 10.1084/jem.20172063, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20172063</ArticleId><ArticleId IdType="pmc">PMC5940269</ArticleId><ArticleId IdType="pubmed">29549113</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng F, Twardowski L, Fehr S, Aner C, Schaeffeler E, Joos T, et al. . Selective p38α MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: implications for atherosclerosis. FASEB J. (2017) 31:674–86. doi: 10.1096/fj.201600669R, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600669R</ArticleId><ArticleId IdType="pubmed">27871059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Zhang W, Choi M, Zhao J, Gao P, Xue M, et al. . Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation. Redox Biol. (2019) 22:101137. doi: 10.1016/j.redox.2019.101137, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101137</ArticleId><ArticleId IdType="pmc">PMC6377391</ArticleId><ArticleId IdType="pubmed">30771750</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera DG, Robertson HA. Activation of C-Fos in the brain. Prog Neurobiol. (1996) 50:83–107. doi: 10.1016/s0301-0082(96)00021-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0301-0082(96)00021-4</ArticleId><ArticleId IdType="pubmed">8971979</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Li X, Wang H, Nie K, Meng Q, He J, et al. . Puerarin: a potential therapeutic for SARS-CoV-2 and hantavirus co-infection. Front Immunol. (2022) 13:892350. doi: 10.3389/fimmu.2022.892350, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.892350</ArticleId><ArticleId IdType="pmc">PMC9161725</ArticleId><ArticleId IdType="pubmed">35663983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe A, Pietropaoli S, Vos M, Barba-Spaeth G, Zurzolo C. Tunneling nanotubes provide a route for SARS-CoV-2 spreading. Sci Adv. (2022) 8:eabo0171. doi: 10.1126/sciadv.abo0171, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abo0171</ArticleId><ArticleId IdType="pmc">PMC9299553</ArticleId><ArticleId IdType="pubmed">35857849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, Lu D, Scully M, Kakkar V. The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy. Perspect Medicin Chem. (2008) 2:57–73. doi: 10.1177/1177391X0800200003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1177391X0800200003</ArticleId><ArticleId IdType="pmc">PMC2746574</ArticleId><ArticleId IdType="pubmed">19787098</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke NE, Fisher MJ, Porter KE, Lambert DW, Turner AJ. Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling. PLoS One. (2012) 7:e34747. doi: 10.1371/journal.pone.0034747, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034747</ArticleId><ArticleId IdType="pmc">PMC3327712</ArticleId><ArticleId IdType="pubmed">22523556</ArticleId></ArticleIdList></Reference><Reference><Citation>Amruta N, Chastain WH, Paz M, Solch RJ, Murray-Brown IC, Befeler JB, et al. . SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. Cytokine Growth Factor Rev. (2021) 58:1–15. doi: 10.1016/j.cytogfr.2021.02.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.02.002</ArticleId><ArticleId IdType="pmc">PMC7894219</ArticleId><ArticleId IdType="pubmed">33674185</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Raventós B, Roel E, Pistillo A, Martinez-Hernandez E, Delmestri A, et al. . Association between COVID-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. (2022) 376:e068373. doi: 10.1136/bmj-2021-068373, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068373</ArticleId><ArticleId IdType="pmc">PMC8924704</ArticleId><ArticleId IdType="pubmed">35296468</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggelaar MP, den Dulk H, Florea BI, Fazio D, Bernabò N, Raspa M, et al. . ABHD2 inhibitor identified by activity-based protein profiling reduces acrosome reaction. ACS Chem Biol. (2019) 14:2295–304. doi: 10.1021/acschembio.9b00640, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.9b00640</ArticleId><ArticleId IdType="pmc">PMC6878212</ArticleId><ArticleId IdType="pubmed">31525885</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Kenny SJ, Mannowetz N, Mansell SA, Wojcik M, Mendoza S, et al. . Asymmetrically positioned Flagellar control units regulate human sperm rotation. Cell Rep. (2018) 24:2606–13. doi: 10.1016/j.celrep.2018.08.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.08.016</ArticleId><ArticleId IdType="pmc">PMC6177234</ArticleId><ArticleId IdType="pubmed">30184496</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Mannowetz N, Iavarone AT, Safavi R, Gracheva EO, Smith JF, et al. . Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone. Science. (2016) 352:555–9. doi: 10.1126/science.aad6887, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad6887</ArticleId><ArticleId IdType="pmc">PMC5373689</ArticleId><ArticleId IdType="pubmed">26989199</ArticleId></ArticleIdList></Reference><Reference><Citation>Donders GGG, Bosmans E, Reumers J, Donders F, Jonckheere J, Salembier G, et al. . Sperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: a prospective, observational study and validation of the SpermCOVID test. Fertil Steril. (2022) 117:287–96. doi: 10.1016/j.fertnstert.2021.10.022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2021.10.022</ArticleId><ArticleId IdType="pmc">PMC8685303</ArticleId><ArticleId IdType="pubmed">34937665</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Xiao X, Zhang J, Zafar MI, Wu C, Long Y, et al. . Impaired spermatogenesis in COVID-19 patients. EClinicalMedicine. (2020) 28:100604. doi: 10.1016/j.eclinm.2020.100604, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100604</ArticleId><ArticleId IdType="pmc">PMC7584442</ArticleId><ArticleId IdType="pubmed">33134901</ArticleId></ArticleIdList></Reference><Reference><Citation>He T, Shang J, Gao C, Guan X, Chen Y, Zhu L, et al. . A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2/FOXC1 axis. Acta Pharm Sin B. (2021) 11:708–26. doi: 10.1016/j.apsb.2020.11.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7982432</ArticleId><ArticleId IdType="pubmed">33777677</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D, Tran V, Shirazian A, Velasco-Gonzalez C, Iwuchukwu I. Anti-inflammatory genes in PBMCs post-spontaneous intracerebral hemorrhage. Transl Neurosci. (2021) 12:58–66. doi: 10.1515/tnsci-2021-0003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/tnsci-2021-0003</ArticleId><ArticleId IdType="pmc">PMC7844114</ArticleId><ArticleId IdType="pubmed">33564466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Yao J, Chen S, Mao Z, Brinton RD. Allopregnanolone reverses bioenergetic deficits in female triple transgenic Alzheimer’s mouse model. Neurotherapeutics. (2020) 17:178–88. doi: 10.1007/s13311-019-00793-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00793-6</ArticleId><ArticleId IdType="pmc">PMC7053503</ArticleId><ArticleId IdType="pubmed">31664643</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Kim J, Insolera R, Peng X, Fink DJ, Mata M. Rho GTPase regulation of α-synuclein and VMAT2: implications for pathogenesis of Parkinson’s disease. Mol Cell Neurosci. (2011) 48:29–37. doi: 10.1016/j.mcn.2011.06.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2011.06.002</ArticleId><ArticleId IdType="pmc">PMC3163163</ArticleId><ArticleId IdType="pubmed">21699982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fred SM, Kuivanen S, Ugurlu H, Casarotto PC, Levanov L, Saksela K, et al. . Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine shows antiviral activity against the novel variants in vitro. Front Pharmacol. (2021) 12:755600. doi: 10.3389/fphar.2021.755600, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.755600</ArticleId><ArticleId IdType="pmc">PMC8809408</ArticleId><ArticleId IdType="pubmed">35126106</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwaar MU, Adnan F, Abro A, Khan RA, Rehman AU, Osama M, et al. . Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. Comput Biol Med. (2022) 141:105049. doi: 10.1016/j.compbiomed.2021.105049, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105049</ArticleId><ArticleId IdType="pmc">PMC8604796</ArticleId><ArticleId IdType="pubmed">34823857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall DC, Ji H-F. A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease. Travel Med Infect Dis. (2020) 35:101646. doi: 10.1016/j.tmaid.2020.101646, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101646</ArticleId><ArticleId IdType="pmc">PMC7152904</ArticleId><ArticleId IdType="pubmed">32294562</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay O, Arif M, Li X, Yang H, Aydın M, Alkurt G, et al. . Combined metabolic activators accelerates recovery in mild-to-moderate COVID-19. Adv Sci. (2021) 8:e2101222. doi: 10.1002/advs.202101222, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202101222</ArticleId><ArticleId IdType="pmc">PMC8420376</ArticleId><ArticleId IdType="pubmed">34180141</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy AA-B. Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide. Biosci Rep. (2020) 40:BSR20202856. doi: 10.1042/BSR20202856, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20202856</ArticleId><ArticleId IdType="pmc">PMC7601349</ArticleId><ArticleId IdType="pubmed">33063092</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T, Yoshinaga SK, Shibue K, Mak TW. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ. (2021) 28:3199–213. doi: 10.1038/s41418-021-00892-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00892-y</ArticleId><ArticleId IdType="pmc">PMC8522258</ArticleId><ArticleId IdType="pubmed">34663907</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma AK, Lowery S, Lin L-C, Duraisami E, Lloréns JEA, Qiu Q, et al. . (2024). Persistent neurological deficits in mouse PASC reveal antiviral drug limitations. bioRxiv. Available at: 10.1101/2024.06.02.596989. [Epub ahead of preprint]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.06.02.596989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JD, Solomon IH, Slack FJ, Mavrikaki M. Cognition-associated long noncoding RNAs are dysregulated upon severe COVID-19. Front Immunol. (2024) 15:1290523. doi: 10.3389/fimmu.2024.1290523, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1290523</ArticleId><ArticleId IdType="pmc">PMC10894962</ArticleId><ArticleId IdType="pubmed">38410515</ArticleId></ArticleIdList></Reference><Reference><Citation>Griggs E, Trageser K, Naughton S, Yang E-J, Mathew B, Van Hyfte G, et al. . Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects. eLife. (2023) 12:e86333. doi: 10.7554/eLife.86333, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86333</ArticleId><ArticleId IdType="pmc">PMC10361716</ArticleId><ArticleId IdType="pubmed">37417740</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu WT, Kaluzova M, Dawson A, Sotelo V, Papas J, Lemenze A, et al. . Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairment. Cell Rep Med. (2024) 5:101561. doi: 10.1016/j.xcrm.2024.101561, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2024.101561</ArticleId><ArticleId IdType="pmc">PMC11148803</ArticleId><ArticleId IdType="pubmed">38744274</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna VD, Chang A, Korthas H, Var SR, Low WC, Li L, et al. . (2023). Impact of age and sex on neuroinflammation following SARS-CoV-2 infection in a murine model. bioRxiv. Available at: 10.1101/2023.08.11.552998. [Epub ahead of preprint]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.08.11.552998</ArticleId><ArticleId IdType="pmc">PMC11284165</ArticleId><ArticleId IdType="pubmed">39077737</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>